Pulsatile Electrical Impedance Tomography for Diagnosis and Monitoring of Acute Pulmonary Embolism (EIT-PE)
A Multicenter Retrospective and Prospective Diagnostic Observational Study of Pulsatile Electrical Impedance Tomography for Diagnosis, Risk Stratification, and Dynamic Monitoring of Acute Pulmonary Embolism
연구 개요
상세 설명
Pulmonary embolism is an important type of venous thromboembolism and may be associated with substantial morbidity and mortality. CT pulmonary angiography is commonly used as the reference standard for diagnosis, but it has limitations, including radiation exposure, use of iodinated contrast agents, and limited feasibility for continuous bedside monitoring in some critically ill patients.
Electrical impedance tomography is a noninvasive functional imaging technique that can be performed at the bedside and does not involve radiation. This study will evaluate a pulsatile EIT-based approach for assessing pulmonary ventilation and perfusion. The main EIT-derived parameters include the ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index.
The retrospective phase will collect existing clinical and EIT data from patients with CTPA-confirmed acute pulmonary embolism and healthy controls. These data will be used to compare EIT parameters between groups, evaluate diagnostic performance, and explore optimal cutoff values.
The prospective phase will enroll patients newly diagnosed with acute pulmonary embolism and healthy volunteers. EIT examinations will be performed during routine clinical evaluation and follow-up. EIT parameters will be compared with CTPA findings, clinical risk stratification, D-dimer levels, echocardiographic indicators, and clinical outcomes. For patients with pulmonary embolism, serial EIT measurements may be used to evaluate dynamic changes during treatment and follow-up.
This is an observational study. Participants will not be assigned to any treatment by the study protocol, and clinical management will be determined by the treating physicians according to routine clinical practice.
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: jiazheng LI, MD
- 전화번호: +86-18810886832
- 이메일: ljzs00357@btch.edu.cn
연구 연락처 백업
- 이름: weiwei wu, MD
- 전화번호: +86-13426397036
- 이메일: weiwei.wu@btch.edu.cn
연구 장소
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, 중국, 102218
- 아직 모집하지 않음
- Beijing Tsinghua Changgung Hospital
-
연락하다:
- jiazheng LI, MD
- 전화번호: +86-18810886832
- 이메일: ljzs00357@btch.edu.cn
-
연락하다:
- weiwei wu, MD
- 전화번호: +86-13426397036
- 이메일: weiwei.wu@btch.edu.cn
-
수석 연구원:
- weiwei wu, MD
-
Beijing, Beijing Municipality, 중국, 100730
- 아직 모집하지 않음
- Peking Union Medical College Hospital
-
연락하다:
- YUN LONG, MD
- 전화번호: +86-10-69155707
- 이메일: 2801634102@qq.com
-
부수사관:
- yun long, MD
-
-
Hunan
-
Chenzhou, Hunan, 중국, 423000
- 모병
- Chenzhou First People's Hospital
-
연락하다:
- shaofei xu, MD
- 전화번호: +86-13617356697
- 이메일: 742025632@qq.com
-
연락하다:
- 이메일: 742025632@qq.com
-
부수사관:
- shaofei xu, MD
-
Loudi, Hunan, 중국, 417000
- 아직 모집하지 않음
- Loudi Central Hospital
-
연락하다:
- junbiao huang, MD
- 전화번호: +8618873820320
- 이메일: 695997696@qq.com
-
부수사관:
- junbiao huang, MD
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Adults aged 18 years or older. For retrospective PE cases: patients with acute pulmonary embolism confirmed by CT pulmonary angiography, with completed pulsatile electrical impedance tomography examination, adequate image data, and available clinical information.
For retrospective healthy controls: adults without evidence of lower-extremity venous thrombosis, with normal D-dimer levels, simplified Wells score ≤1, and no pulmonary embolism-related symptoms or history.
For prospective PE patients: patients newly diagnosed with pulmonary embolism by CT pulmonary angiography or CT pulmonary angiography plus CT venography, with body mass index less than 50 kg/m², who voluntarily participate and provide written informed consent.
For prospective non-PE controls: patients with suspected acute pulmonary embolism who undergo CT pulmonary angiography or CT pulmonary angiography plus CT venography, but in whom pulmonary embolism is not confirmed, who voluntarily participate and provide written informed consent.
Exclusion Criteria:
- Previous diagnosis of chronic pulmonary embolism or idiopathic pulmonary arterial hypertension.
Acute exacerbation of chronic obstructive pulmonary disease, acute heart failure, acute myocardial infarction, or other severe cardiopulmonary diseases that may interfere with study assessment.
Pregnancy or lactation. Thoracic deformity. Contraindications to EIT examination, including automatic implantable cardioverter defibrillator, chest wounds limiting electrode belt placement, implanted pumps, or other conditions unsuitable for EIT electrode belt placement.
Participation in another clinical trial during the same period, for prospective participants.
Unstable vital signs requiring emergency rescue, leaving no time to complete EIT examination, for prospective participants.
Any other condition considered unsuitable for participation by the investigators.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Retrospective PE Cases
Patients aged 18 years or older with acute pulmonary embolism confirmed by CT pulmonary angiography, with completed pulsatile electrical impedance tomography examination and available clinical data in the retrospective phase.
|
Pulsatile electrical impedance tomography will be used to obtain EIT-derived parameters, including the ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index.
These parameters will be compared with CT pulmonary angiography and clinical indicators to evaluate the diagnostic performance, risk stratification value, and dynamic monitoring value of EIT in acute pulmonary embolism.
This diagnostic assessment does not assign participants to treatment and does not alter routine clinical management.
다른 이름들:
|
|
Retrospective Healthy Controls
Adults in the retrospective phase without evidence of lower-extremity venous thrombosis, with normal D-dimer levels, simplified Wells score ≤1, and no pulmonary embolism-related symptoms or history.
|
Pulsatile electrical impedance tomography will be used to obtain EIT-derived parameters, including the ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index.
These parameters will be compared with CT pulmonary angiography and clinical indicators to evaluate the diagnostic performance, risk stratification value, and dynamic monitoring value of EIT in acute pulmonary embolism.
This diagnostic assessment does not assign participants to treatment and does not alter routine clinical management.
다른 이름들:
|
|
Prospective PE Patients
Patients aged 18 years or older newly diagnosed with pulmonary embolism by CT pulmonary angiography or CT pulmonary angiography plus CT venography, who voluntarily participate and provide written informed consent.
|
Pulsatile electrical impedance tomography will be used to obtain EIT-derived parameters, including the ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index.
These parameters will be compared with CT pulmonary angiography and clinical indicators to evaluate the diagnostic performance, risk stratification value, and dynamic monitoring value of EIT in acute pulmonary embolism.
This diagnostic assessment does not assign participants to treatment and does not alter routine clinical management.
다른 이름들:
|
|
Prospective Non-PE Controls
Patients aged 18 years or older with suspected acute pulmonary embolism who undergo CT pulmonary angiography or CT pulmonary angiography plus CT venography, but in whom pulmonary embolism is not confirmed.
These participants voluntarily participate and provide written informed consent in the prospective phase.
|
Pulsatile electrical impedance tomography will be used to obtain EIT-derived parameters, including the ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index.
These parameters will be compared with CT pulmonary angiography and clinical indicators to evaluate the diagnostic performance, risk stratification value, and dynamic monitoring value of EIT in acute pulmonary embolism.
This diagnostic assessment does not assign participants to treatment and does not alter routine clinical management.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Diagnostic performance of EIT-derived MI, DI, and SI for acute pulmonary embolism
기간: At baseline or index EIT assessment
|
The diagnostic performance of EIT-derived ventilation-perfusion matching index, dead-space ventilation index, and intrapulmonary shunt index for distinguishing acute pulmonary embolism from non-PE controls will be evaluated using the area under the receiver operating characteristic curve, sensitivity, specificity, positive predictive value, negative predictive value, and optimal cutoff values, with CT pulmonary angiography as the reference standard.
|
At baseline or index EIT assessment
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Correlation between EIT-derived parameters and CTPA embolic burden
기간: At baseline or index assessment
|
The correlation between MI, DI, SI and the embolic burden assessed by CT pulmonary angiography will be analyzed.
|
At baseline or index assessment
|
|
Differences in EIT-derived parameters across thrombus locations and clinical risk strata
기간: At baseline or index assessment
|
MI, DI, and SI will be compared among patients with different thrombus locations and different clinical risk strata.
|
At baseline or index assessment
|
|
Correlation between EIT-derived parameters and clinical indicators
기간: At baseline or index assessment
|
The correlation between MI, DI, SI and clinical indicators, including D-dimer levels and echocardiographic indicators of right heart function, will be analyzed.
|
At baseline or index assessment
|
|
Dynamic changes in EIT-derived parameters during treatment and follow-up
기간: Baseline, 48 hours after thrombolytic treatment when applicable, before discharge, and 1 month after discharge
|
Changes and percentage changes in MI, DI, and SI will be assessed at baseline, during treatment when applicable, before discharge, and at 1 month after discharge.
|
Baseline, 48 hours after thrombolytic treatment when applicable, before discharge, and 1 month after discharge
|
공동 작업자 및 조사자
협력자
수사관
- 수석 연구원: weiwei Wu, MD, Beijing Tsinghua Changgeng Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 2D-EIT-PE-2026
- L246021 (기타 보조금/기금 번호: Beijing Natural Science Foundation-Daxing Innovation Joint Fund)
- 26890-0-01 (기타 식별자: Institutional Review Board of Beijing Tsinghua Changgung Hospital)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .